Fibrobiologics Inc（FBLG）价格预测FBLGFibrobiologics Inc

Alphio's FBLG stock price prediction model matches the current Fibrobiologics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.16 (+2.27%). The 1-week path is $1.97 (-6.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Fibrobiologics Inc is currently not a strong buy due to its significant losses and high volatility. The current price is $1.44, with an RSI of 69.308 indicating it may be overbought. The forward P/E ratio is negative, and the company reported a net income loss of $5 million in Q1 2026. While there are positive developments such as the ongoing clinical trials for the CYWC628 drug and insider buying activity increasing by 358.82%, the risks of continued financial losses and market sentiment pressure suggest caution. The main risk is the company's ongoing negative earnings, with a projected EPS of -0.93 in the last earnings report, which could lead to further stock price declines.

Fibrobiologics Inc (FBLG) last closed at $2.11, gaining +22.67%. These facts feed the 1-day and 1-week FBLG price prediction above.